Аnalysis of the market of medicinal products for the conservative treatment of hemorrhoids in order to determine the marketing opportunities for a domestic manufacturer
The spread of diseases of the rectum, namely hemorrhoids, leads to the deterioration of the physical and psychological health of the working-age population, increases the budget costs of the healthcare system, insurance companies, and the population’s own funds. In this regard, the development of new complex medicinal products is always relevant for domestic pharmacy.
Aim. To form a modern idea of the market structure and trends in the consumption of drugs for the conservative treatment of hemorrhoids, determine the possible potential for domestic developers and manufacturers.
Materials and methods. The research was conducted using the structural analysis logical and graphic methods, methods of marketing analysis.
Results. It was found that recently the market of antihemoroidal agents for topical application and capillary-stabilizing agents developed quite vigorously – the market growth rates in the period of 2020-2021 were from 15 to 23 % in physical units and from 28 to 40 % in monetary units. However, according to the structure of the producing countries, the market remains import-dependent. Drugs from France, Switzerland, Bulgaria, Germany, Spain, Slovenia, Italy, and the United States are available on the market. The leaders of sales are products manufactured by Servier (France), Innotek International (France), and Teva (Israel). The leaders in the supply of domestic drugs of this group are Borshchagovsky Chemical Pharmaceutical Plant, JSC “Galichpharm”, Kyiv Vitamin Plant, PJSC “Darnitsa” Pharmaceutical company”, PJSC “Monpharm”. The most popular dosage forms are tablets, capsules, gels, ointments, suppositories.
Conclusions. Based on the changes identified, certain proposals have been developed for the domestic pharmaceutical industry – the market has a relatively small range of domestic complex medicines combining components of chemical and natural origin, including the plant raw material. The market has a positive development trend; therefore, further search for an effective complex drug is expedient.
Davis, B. R., Lee-Kong, S. A., Migaly, J., Feingold, D. L., Steele, S. R. (2018). The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Dis Colon Rectum, 61 (3), 284-292. doi: 10.1097/DCR.0000000000001030.
Coughlin, O. P., Wright, M. E., Thorson, A. G., Ternent, C. A. (2019). Hemorrhoid banding: a cost-effectiveness analysis. Dis Colon Rectum., 62 (9), 1085-1094. doi: 10.1097/DCR.0000000000001444.
Watson, A. J., Hudson, J., Wood, J., Kilonzo, M., Brown, S. R., McDonald, A. et al. (2016). Comparison of stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease (eTHoS): a pragmatic, multicentre, randomised controlled trial. Lancet, 388 (10058), 2375-2385. doi: https://doi.org/10.1016/S0140-6736(16)31803-7.
Simillis, C., Thoukididou, S. N., Slesser, A. A., Rasheed, S., Tan, E., Tekkis, P. P. (2015). Systematic review and network meta-analysis comparing clinical outcomes and effectiveness of surgical treatments for haemorrhoids. Br J Surg., 102 (13), 1603-1618. doi: 10.1002/bjs.9913.
Ferrandis, C., De Faucal, D., Fabreguette, J. M., Borie, F. (2020). Efficacy of Doppler-guided hemorrhoidal artery ligation with mucopexy, in the short and long terms for patients with hemorrhoidal disease. Tech Coloprocto, 24 (2), 165-171. doi: 10.1007/s10151-019-02136-1.
Muldoon, R. (2020). The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. JAMA Surgery, 155 (8), 773-774. doi: 10.1001/jamasurg.2020.0788.
Shmalii, Ye. I. Orlovetska, N. F. (2021). Proceeding from Tekhnolohichni ta biofarmatsevtychni aspekty stvorennia likarskykh preparativ riznoi napravlenosti dii : materialy VI Mizhnar. nauk.-prakt. internet-konf. (11-12 lystopada 2021 r.). (pp. 509-512). Kharkiv.
Havlickova, B. (2010). Topical corticosteroid therapy in proctology indications. Alimentary pharmacology & therapeutics, 31, 19–32.
Borodin, V. V. Buriak, M. V., Khokhlenkova, N. V. (2019). Proceeding from Suchasni dosiahnennia farmatsevtychnoi tekhnolohii i biotekhnolohii : zb. nauk. pr. (Vyp. 6). (pp. 93). Kharkiv.
Zinchenko, M. R., Rukhmakova, O. A. (2020). Proceeding from Tekhnolohichni ta biofarmatsevtychni aspekty stvorennia likarskykh preparativ riznoi napravlenosti dii : materialy V Mizhnar. nauk.-prakt. internet - konf. (26 lystopada 2020 r.). (pp. 192-193). Kharkiv.
Kovalevska, I. V., Borko, Ye. A. (2019). Proceeding from Suchasna farmatsiia: istoriia, realii ta perspektyvy rozvytku : materialy nauk.-prakt. konf. z mizhnar. uchastiu, prysviachenoi 20-i richnytsi zasnuvannia Dnia farmatsevtychnoho pratsivnyka Ukrainy (19-20 veresnya). (рр. 273-274). Kharkiv.
Borodin, V. B., Khokhlenkova, N. V. (2020). Proceeding from Suchasni dosiahnennia farmatsevtychnoi nauky v stvorenni ta standartyzatsii likarskykh zasobiv i diietychnykh dobavok, shcho mistiat komponenty pryrodnoho pokhodzhennia : materialy II Mizhnar. nauk.-prakt. internet-konf. (11 bereznia 2020 r.). (pp. 29-30). Kharkiv.
Borko, Yu. A., Kovalevska, I. V., Ruban, O. A., Kutova, O. V. (2022). Farmatsevtychnii zhurnal, 1, 74-85. doi: doi.org/10.32352/0367-3057.1.22.07.
Borko, Y., Kovalevska, I., Grudko, V., Kononenko, N., Velya, M. (2022). Comprehensive study for the development of rectal suppositories with diosmin and hesperidin. ScienceRise: Pharmaceutical Science, 1 (35), 14-21.
Bezchasniuk, O. M. (2017). Upravlinnia yakistiu v farmatsii : materialy XI nauk.-prakt. konf. z mizhnar. uchastiu (19 travnia 2017 r.). (pp. 28). Kharkiv.
Onyshkiv, O. I. (2014). Farmatsevtychnyi chasopys, 2, 66-69.
Oliinyk, I. M., Fedenko, S. M., Fedorovska, M. I. (2018). Pharmaceutical review, 1, 81-86.
Baza danykh “Ekvalaizer” TOV “Biznes-Kredyt”. Available at: http://eq.bck.com.ua/.
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: http://www.drlz.com.ua/.
Kompendium: lekarstvennye preparaty. Available at: http://compendium.com.ua.
Kuznetsova, V. M., Shulha, L. Y, Rolik, S. N. (2021). Shchotyzhnevyk Apteka, 24 (945). Available at: https://www.apteka.ua/article/295327.
Harna, S. V., Vladymyrova, I. M., Burda, N. B. et al. (2016). Suchasna fitoterapiia. Kharkiv: Drukarnia Madryd, 580.
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).